SS 43 - Lung 5: Locally Advanced NSCLC: PORT and Cardiac Toxicity

Presentations

• 04:00pm - 04:10pm PT

  Differential Survival Benefits of PORT in AJCC-9th /IASLC-Defined N2 NSCLC Substages: A Multicenter Real-World Study

  Speaker: Yongxing Bao, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC, Beijing
• 04:00pm - 05:00pm PT

  Lung 5: Locally Advanced NSCLC: PORT and Cardiac Toxicity

  Speaker: Jeffrey Bradley, MD, FASTRO - University of Pennsylvania, Philadelphia
• 04:00pm - 05:00pm PT

  Lung 5: Locally Advanced NSCLC: PORT and Cardiac Toxicity

  Speaker: Stephen Chun, MD - MD Anderson Cancer Center, Houston
• 04:10pm - 04:20pm PT

  Differential Prognostic Impact of Distant and Locoregional Recurrence on Survival in Surgically Resected Pathologic N2 NSCLC: Multicenter Dynamic Prediction with Landmark Model

  Speaker: Zeliang Ma, MD - Mayo Clinic Rochester, Rochester
• 04:20pm - 04:30pm PT

  Impact of AI-Based Coronary Artery Calcium (CAC) Scores and Heart Dose on Survival in Locally-Advanced Non-Small-Cell Lung Cancer (LA-NSCLC): A Secondary Analysis of RTOG 0617

  Speaker: Nilanjan Haldar, MD, BS - Thomas Jefferson University, Philadelphia
• 04:30pm - 04:40pm PT

  Epicardial Fat as a Radiomic Predictor of Cardiac Outcomes following Thoracic Radiotherapy for Lung Cancer

  Speaker: Qiao Jiao, MS, BS, BA - Harvard Medical School, Boston
• 04:40pm - 04:50pm PT

  Dosimetric Parameters of the Heart and its Substructures Predicting Survival and Cardiac Events in Lung Cancer Patients after Radiotherapy: A Systematic Review and Meta-Analysis

  Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang
• 04:50pm - 05:00pm PT

  Discussant

  Speaker: George Rodrigues, MD, PhD, FASTRO - London Health Sciences Centre, London